Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Gala

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|June 25, 1998
Sensitivity or specificity of reverse transcriptase-polymerase chain reaction assays: the real challenge for molecular staging of prostatic carcinomasJ L Gala, S Loric
European Urology|July 3, 2007
Editorial commentB Tombal, J L Gala
Diabetic Medicine : a Journal of the British Diabetic Association|May 10, 2006
The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetesM P Hermans, J-L Gala, M Buysschaert
World Journal of Urology|August 5, 2000
Intermittent endocrine treatmentP J Van Cangh, B Tombal, J L Gala
The Prostate. Supplement|November 1, 2000
Immediate vs. delayed androgen deprivation for prostate cancerP J Van Cangh, J L Gala, B Tombal
Clinical Chemistry|November 4, 1998
Detection of intracellular antigens by flow cytometry: comparison of two chemical methods and microwave heatingI Millard, E Degrave, M Philippe, et al.
Infection|October 31, 1998
Acute hepatitis in a patient treated with saquinavir and ritonavir: absence of cross-toxicity with indinavirB Vandercam, M Moreau, C Horsmans, et al.
Diabetes & Metabolism|November 5, 2004
C677T methylene-tetrahydrofolate reductase mutation in type 2 diabetic patients with and without hyperhomocysteinaemiaM Buysschaert, J L Gala, A Bessomo, et al.
Leukemia Research|October 10, 1998
Introduction of a normal retinoblastoma (Rb) gene into Rb-deficient lymphoblastoid cells delays tumorigenicity in immunodefective miceD Lefebvre, J L Gala, M Heusterspreute, et al.
The Journal of Urology|April 29, 1998
Re: reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancerP Berteau, F Dumas, S Loric, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|June 25, 1998
Sensitivity or specificity of reverse transcriptase-polymerase chain reaction assays: the real challenge for molecular staging of prostatic carcinomasJ L Gala, S Loric
European Urology|July 3, 2007
Editorial commentB Tombal, J L Gala
Diabetic Medicine : a Journal of the British Diabetic Association|May 10, 2006
The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetesM P Hermans, J-L Gala, M Buysschaert
World Journal of Urology|August 5, 2000
Intermittent endocrine treatmentP J Van Cangh, B Tombal, J L Gala
The Prostate. Supplement|November 1, 2000
Immediate vs. delayed androgen deprivation for prostate cancerP J Van Cangh, J L Gala, B Tombal
Clinical Chemistry|November 4, 1998
Detection of intracellular antigens by flow cytometry: comparison of two chemical methods and microwave heatingI Millard, E Degrave, M Philippe, et al.
Infection|October 31, 1998
Acute hepatitis in a patient treated with saquinavir and ritonavir: absence of cross-toxicity with indinavirB Vandercam, M Moreau, C Horsmans, et al.
Diabetes & Metabolism|November 5, 2004
C677T methylene-tetrahydrofolate reductase mutation in type 2 diabetic patients with and without hyperhomocysteinaemiaM Buysschaert, J L Gala, A Bessomo, et al.
Leukemia Research|October 10, 1998
Introduction of a normal retinoblastoma (Rb) gene into Rb-deficient lymphoblastoid cells delays tumorigenicity in immunodefective miceD Lefebvre, J L Gala, M Heusterspreute, et al.
The Journal of Urology|April 29, 1998
Re: reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancerP Berteau, F Dumas, S Loric, et al.
Pageof 5